Identification of protective pneumococcal TH17 antigens from the soluble fraction of a killed whole cell vaccine

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Moffitt, Kristin L ^a   Malley, Richard ^a   Lu, Ying Jie ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CHOLERA TOXIN; INTERLEUKIN 17; PNEUMOCOCCUS VACCINE; RECOMBINANT PROTEIN; SP 0435; SP 0516; SP 0862; SP 0946; SP 1297; SP 1415; SP 1458; SP 1534; SP 1572; SP 1733; SP 2070; SP 2092; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; WHOLE CELL ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; BACTERIAL COLONIZATION; CELL STIMULATION; CELL SUSPENSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNOGENICITY; MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONTENT; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SEROTYPE; SPLEEN CELL; TH17 CELL; WHOLE CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; ESCHERICHIA COLI; IMMUNIZATION; INTERLEUKIN-17; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SPLEEN; STREPTOCOCCUS PNEUMONIAE; TH17 CELLS;

EID: 84865053413     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043445     Document Type: Article

References (22)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
2. Isaacman DJ, McIntosh ED, Reinert RR, (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14: e197-209.
3. Hsu KK, Shea KM, Stevenson AE, Pelton SI, (2010) Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J 29: 289-293.
4. Weinberger DM, Malley R, Lipsitch M, (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962-1973.
5. Moffitt KL, Malley R, (2011) Next generation pneumococcal vaccines. Current opinion in immunology 23: 407-413.
6. Malley R, Lipsitch M, Stack A, Saladino R, Fleisher G, et al. (2001) Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun 69: 4870-4873.
7. Lu YJ, Leite L, Goncalves VM, Dias Wde O, Liberman C, et al. (2010) GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis. Vaccine 28: 7468-7475.
8. Lu YJ, Yadav P, Clements JD, Forte S, Srivastava A, et al. (2010) Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine. Clin Vaccine Immunol 17: 1005-1012.
9. Moffitt KL, Yadav P, Weinberger DM, Anderson PW, Malley R (In press) Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine. Vaccine.
10. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, et al. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159.
11. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, et al. (2005) CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A 102: 4848-4853.
12. CDC (2005) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54: 893-897.
13. Basset A, Thompson CM, Hollingshead SK, Briles DE, Ades EW, et al. (2007) Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun 75: 5460-5464.
14. Moffitt KL, Gierahn TM, Lu YJ, Gouveia P, Alderson M, et al. (2011) T(H)17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization. Cell Host Microbe 9: 158-165.
15. Wizemann TM, Heinrichs JH, Adamou JE, Erwin AL, Kunsch C, et al. (2001) Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 69: 1593-1598.
16. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, et al. (2008) Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 205: 117-131.
17. Andersen P, Askgaard D, Gottschau A, Bennedsen J, Nagai S, et al. (1992) Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scandinavian journal of immunology 36: 823-831.
18. Medina M, Villena J, Vintini E, Hebert EM, Raya R, et al. (2008) Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infection and immunity 76: 2696-2705.
19. Green BA, Zhang Y, Masi AW, Barniak V, Wetherell M, et al. (2005) PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Infection and immunity 73: 981-989.
20. Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, et al. (2004) Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clinical and experimental immunology 138: 290-298.
21. Lu YJ, Forte S, Thompson CM, Anderson PW, Malley R, (2009) Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide. Infect Immun 77: 2076-2083.
22. Lu YJ, Zhang F, Sayeed S, Thompson CM, Szu S, et al. (2012) A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi. Vaccine 30: 3405-3412.